Business NewsNewsPhysiciansProduct News

PENUMBRA ACQUIRES 90% OF MVI HEALTH JV, LAUNCHES THROMBECTOMY DEVICES

 

Penumbra has acquired 40 percent of the outstanding shares of virtual reality joint venture MVI Health from collaborator Sixense, boosting its interest to 90 percent, and said it launched the Penumbra Jet 7 and Jet D reperfusion catheters.

The joint venture intends to commercialize healthcare applications of virtual reality technology, Alameda, Calif.-based Penumbra officials said, though more information on the specifics of the technology has not yet emerged.

A Penumbra spokesman said it paid $20 million to Sixense to acquire the additional 40 percent interest in a deal with contains an anti-dilution provision intended to allow Penumbra to issue additional MVI shares to Sixense with an aggregate value of up to $4.5 million, according to an SEC filing.

The company also announced the launch of its Jet 7 and Jet D reperfusion catheters, which are part of its Penumbra aspiration-based thrombectomy system intended for stroke revascularization.

The Jet 7 is the company’s seventh generation reperfusion catheters designed fro proximal large vessel occlusions, while the Jet D is designed specifically for distal occlusions, according to.

“The Jet 7 reperfusion catheter with its advanced tracking technology and large 0.072″ aspiration lumen is the most advanced device for stroke,” Alejandro Spiotta, MD, of the Medical University of South Carolina, said in a prepared statement.

“In my clinical experience, I was able to easily and quickly navigate the Jet 7 through tortuous anatomy to the face of the clot and achieve full revascularization after a single pass. We know from our own published experience that increases in aspiration lumen size have led to faster recanalization times and higher likelihood of success at first pass without compromising safety. I eagerly await collecting and publishing our clinical experience with Jet 7.”

Chairman and CEO Adam Elsesser said Penumbra is delighted to usher in our next phase of innovation with the introduction of the Penumbra Jet 7, Jet D and Engine. “Each phase of innovation – original Penumbra system, Max and Ace systems, and now Jet and Engine – represents a significant improvement in performance and the opportunity to further help patients experiencing acute ischemic stroke,” he stated. VTN

 

Previous post

MEDICAL GROUPS, PATIENT ADVOCATES OPPOSE MEDICARE PLANS TO CONSOLIDATE E/M CODES

Next post

2018 ACP ANNUAL CONGRESS, NOV. 8-11, WILL BE A FRESH BREAK FROM THE PAST

Larry Storer

Larry Storer

Larry Storer has been editor of Vein Therapy News for 10 years. He has edited computer, shelter and medical publications at Publications & Communications LP for 30 years. He was also a corporate vice president and editorial director before retiring. Larry graduated from Baylor University with a BA in journalism and an MA in communications; and from Lamar University with a MED in school administration. He taught beginning and advanced reporting, beginning and advanced editing and editorial writing at Baylor University. Larry was a reporter, and city and news editor of the Beaumont Journal, and opinion editor at the Beaumont Enterprise and Beaumont Enterprise-Journal. He was also the founding managing editor of the Yuba City (California) Daily Independent-Herald.